Int J STD AIDS. 2008 Nov;19(11):786-8.

Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.

Kumarasamy N, Venkatesh KK, Devaleenol B, Poongulali S, Ahilasamy N.

Source

YRG Centre for AIDS Research and Education, Voluntary Health Services, Chennai, India. kumarasamy@yrgcare.org

Abstract

This case report documents that highly active antiretroviral therapy (HAART) can lead to the regression of Kaposi's sarcoma (KS) lesions in the auditory canal of an HIV-infected male from Chennai, India. In resource-limited settings where administering anti-KS chemotherapeutic agents may not be feasible, HAART alone can be an option in HIV-infected individuals with KS.

PMID:: 18931277; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Case Reports

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Management of Kaposi's sarcoma in resource-limited settings in the era of HAART. [AIDS Rev. 2005]
Review Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L, Zolfo M, Huyst V, Louis F, Barnardt P, Van de Velde A, De Schacht C, Colebunders R. AIDS Rev. 2005 Jan-Mar; 7(1):13-21.
Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma. [AIDS. 2004]
Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
Martin-Carbonero L, Barrios A, Saballs P, Sirera G, Santos J, Palacios R, Valencia ME, Alegre M, Podzamczer D, González-Lahoz J, et al. AIDS. 2004 Aug 20; 18(12):1737-40.
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. [AIDS. 2007]
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, et al. AIDS. 2007 Jun 19; 21(10):1245-52.
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. [Br J Cancer. 2006]
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V, Caumes E, Gambotti L, Ittah H, Morini JP, Deleuze J, Gorin I, Katlama C, Bricaire F, Dupin N. Br J Cancer. 2006 Apr 10; 94(7):1000-6.
Review Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. [AIDS Patient Care STDS. 2005]
Review Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.
Leidner RS, Aboulafia DM. AIDS Patient Care STDS. 2005 Oct; 19(10):635-44.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Regression of Kaposi's sarcoma lesions following highly active antiretroviral th...
Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Int J STD AIDS. 2008 Nov ;19(11):786-8.

PubMed
Novel proteins, putative membrane transporters, and an integrated metabolic netw...
Novel proteins, putative membrane transporters, and an integrated metabolic network are revealed by quantitative proteomic analysis of Arabidopsis cell culture peroxisomes.
Plant Physiol. 2008 Dec ;148(4):1809-29. Epub 2008 Oct 17 .

PubMed
Biosynthesis of 7-deazaguanosine-modified tRNA nucleosides: a new role for GTP c...
Biosynthesis of 7-deazaguanosine-modified tRNA nucleosides: a new role for GTP cyclohydrolase I.
J Bacteriol. 2008 Dec ;190(24):7876-84. Epub 2008 Oct 17 .

PubMed
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fib...
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.
J Bacteriol. 2009 Jan ;191(1):261-77. Epub 2008 Oct 17 .

PubMed
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in ...
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
Diabetes Care. 2009 Jan ;32(1):84-90. Epub 2008 Oct 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: